Deciphera Pharmaceuticals Inc. (NASDAQ:DCPH)
Old Forum Content for DCPH
Make a Forum Post Become a member to view recent forum posts. Already a member? Sign in here.- Ajax4Hire: And the complement; $XBI Bio-Technology; Bio=Life; Techno=art/craft/skill; logy=study of BioTechnoLogy=Life-Craft-Study, aren't we all bio-technologist. Hold% $XBI SPDR S&P Biotech ETF - Top 15 holdings 1.79% $NVTA Invitae Corp 1.60% $INO Inovio Pharmaceuticals Inc 1.48% $NVAX Novavax Inc 1.38% $FOLD Amicus Therapeutics Inc 1.23% $ARWR Arrowhead Pharmaceuticals Inc 1.19% $MNTA Momenta Pharmaceuticals Inc 1.17% $ALNY Alnylam Pharmaceuticals Inc 1.16% $EDIT Editas Medicine Inc 1.15% $SAGE SAGE Therapeutics Inc 1.14% $DCPH Deciphera Pharmaceuticals Inc 1.14% $IMMU Immunomedics Inc 1.14% $KPTI Karyopharm Therapeutics Inc 1.13% $ALKS Alkermes Plc 1.12% $INCY Incyte Corp 1.11% $BMRN Biomarin Pharmaceutical Inc Data from: https://ETFdB.com/etf/XBI/#holdings
- efrain007: $DCPH anyone see news on this? Up 20% PM and watching for a trade but I see nothing other than they announced when they will announce earnings.
- issues: @Herb $MIRM Thank you for this addition to my list of the best biotechs: $AUPH $DCPH $ISEE $JNCE $HZNP $AMRN $PFNX $AKBA... we hold AUPH ISEE and others not listed.
- DrScience: $DCPH one to watch tomorrow. Stock up 48% today on positive data release in phase 1 trials, but down in the AH due to stock offering. Hey! If you're going to raise money, best to git it while the gittin' is good. Do your homework and take a position.
Stock Price | $15.73 |
Change | 3.62% |
Volume | 883,135 |
Deciphera Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing new drugs to improve the lives of cancer patients.
Request Video of DCPHAlready a member? Sign in here.
Past Month
Leading Peers
-
$11.94 330.09%
-
$14.14 197.10%
-
$9.49 173.74%
Past Month
Lagging Peers
-
$22.90 -51.95%
-
$5.14 -44.74%
-
$7.59 -41.55%
Dan Fitzpatrick
Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 30 day trial membership for just $7.77. Get started TODAY and start trading better TOMORROW with the following premium content:
- Nightly video Strategy Sessions with a game plan for tomorrow
- Got a stock you want Dan to look at? Just ask.
- Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
- Access to over 90,400 stock analysis videos
- Access an ever expanding library (90,400) of educational videos that will save you time and make you money
Join a team of friends and traders that have one thing in common; a burning desire to succeed.
Become a Member Today!
Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...
Satisfaction Guaranteed!
Your Stock Market Mentor membership comes with a 30 day, no questions asked, 100% money back guarantee!